The epidemiology of parainfluenza virus infection in lung transplant recipients

R A Vilchez1, K McCurry, J Dauber

  • 1Department of Medicine, University of Pittsburgh Medical Center, and Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA.

Insights

Human parainfluenza virus (HPIV) infections are common in lung transplant recipients, often presenting with respiratory symptoms. A significant portion of these patients experienced acute allograft rejection and bronchiolitis obliterans.

Area of Science:

  • Virology
  • Transplantation Immunology
  • Pulmonary Medicine

Background:

  • Human parainfluenza virus (HPIV) causes seasonal respiratory infections.
  • The clinical impact of HPIV in lung transplant recipients remains poorly understood.

Purpose of the Study:

  • To investigate the clinical presentation and outcomes of HPIV infections in lung transplant recipients.

Main Methods:

  • Retrospective review of HPIV infections at a single center from 1990-2000.
  • Analysis of patient demographics, clinical symptoms, HPIV serotypes, and post-infection complications.

Main Results:

  • HPIV infection was identified in 24 (75%) of 32 cases reviewed, occurring a median of 2.1 years post-transplant.
  • Common symptoms included cough and shortness of breath; 21% experienced respiratory failure.
  • HPIV-3 was the most prevalent serotype (63%).
  • 82% of patients with biopsies showed acute allograft rejection, and 32% developed bronchiolitis obliterans.

Conclusions:

  • HPIV infection poses a significant risk for lung transplant recipients.
  • HPIV infection is associated with a high incidence of acute allograft rejection and bronchiolitis obliterans in this population.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...